Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AstraZeneca ADR Representing 0.5 Ord Shs AZN

Consumer Cyclical Healthcare Advertising Agencies
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AZN)

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

Business Wire 19 hours ago

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

Business Wire 2 days ago

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

Business Wire 3 days ago

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca

GlobeNewswire May 6, 2024

CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial

Business Wire May 2, 2024

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

Business Wire May 1, 2024

ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow

Business Wire April 29, 2024

Q1 2024 results

Business Wire April 25, 2024

IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial

Business Wire April 16, 2024
View More News ››

Opinion & Analysis (NDAQ:AZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AZN)

Datopotamab Deruxtecan Biologics License Application Accepte

Just In: $AZN Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced...
whytestocks - February 19, 2024

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

Breaking News: $AZN AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript2024-02-08 16:15:30 ET Image source: The Motley Fool...
whytestocks - February 8, 2024

Hospital Infection Therapeutics Market Size & Share 2021-26

According to IMARC Group’s latest report, titled “Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth...
edwardebreen15 - August 22, 2022

Aztra vaccine coming to Canada soon news?

https://www.msn.com/en-ca/news/newspolitics/health-canada-to-decide-on-astrazeneca-covid-19-vaccine-in-coming-days/ar-BB1ddoDT?ocid...
Rejean1 - January 29, 2021

Conflicting news???

I thought I just read elsewhere they had banned shots to people over 65? A month after it received approval in the UK, the EU’s...
Rejean1 - January 29, 2021

5 dead in Astrazeneca fire in India.

https://www.bbc.com/news/world-asia-india-55753586
Rejean1 - January 21, 2021
View more Bullboard ››

Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies is a clean tech innovation company developing high value, high-performance control systems and ...
View More »